Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: A Systematic Review and Meta-Analysis

Vancomycin (VCM) and daptomycin (DAP) are standard therapies for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia, despite concerns regarding clinical utility and growing resistance. Linezolid (LZD) affords superior tissue penetration to VCM or DAP and has been succes...

Full description

Bibliographic Details
Published in:	Antibiotics
Main Authors:	Hitoshi Kawasuji, Kentaro Nagaoka, Yasuhiro Tsuji, Kou Kimoto, Yusuke Takegoshi, Makito Kaneda, Yushi Murai, Haruka Karaushi, Kotaro Mitsutake, Yoshihiro Yamamoto
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Subjects:	meta-analysis linezolid effectiveness methicillin-resistant <i>Staphylococcus aureus</i> bacteremia
Online Access:	https://www.mdpi.com/2079-6382/12/4/697

Similar Items

Initially Reduced Linezolid Dosing Regimen to Prevent Thrombocytopenia in Hemodialysis Patients
by: Hitoshi Kawasuji, et al.
Published: (2021-04-01)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
by: Nathan B. Pincus, et al.
Published: (2022-01-01)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
by: Navaneeth Narayanan, et al.
Published: (2019-02-01)

A Nanoplex PCR Assay for the Simultaneous Detection of Vancomycin- and Linezolid-Resistant Genes in <i>Enterococcus</i>
by: Yusuf Wada, et al.
Published: (2023-02-01)

Efficacy and safety of linezolid versus teicoplanin for the treatment of MRSA infections: a meta-analysis
by: Hao Chen, et al.
Published: (2018-01-01)

Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption
by: Flaminia Olearo, et al.
Published: (2021-02-01)

High Incidence of Metastatic Infections in Panton-Valentine Leucocidin-Negative, Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia: An 11-Year Retrospective Study in Japan
by: Hitoshi Kawasuji, et al.
Published: (2023-10-01)

Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
by: María-José Valderrama, et al.
Published: (2020-08-01)

Linezolid and vancomycin for nosocomial infections in pediatric patients: a systematic review
by: Bruno Russo Porchera, et al.
Published: (2024-05-01)

Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe
by: Robby Markwart, et al.
Published: (2021-05-01)

Activity of vancomycin combined with linezolid against clinical vancomycin-resistant Enterococcus strains
by: Gulseren Aktas
Published: (2020-07-01)

Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection
by: Szu-Ting Huang, et al.
Published: (2023-04-01)

Antibiotic Combinations Preventing Bacterial Resistance: Studies on an in vitro Model with Staphylococcus aureus Exposed to Linezolid–Daptomycin
by: K. N. Alieva, et al.
Published: (2020-05-01)

Antibiotic Combinations Preventing Bacterial Resistance: Studies on an in vitro Model with Staphylococcus aureus Exposed to Linezolid–Daptomycin
by: K. N. Alieva, et al.
Published: (2020-05-01)

THE EFFECT OF LINEZOLID AGAINST VANCOMYCIN-RESISTANT ENTEROCOCCI BY VARIOUS METHODS
by: Başak Sıla Eyüp, et al.
Published: (2024-02-01)

The Synergistic Activity of Rhamnolipid Combined with Linezolid against Linezolid-Resistant <i>Enterococcus faecium</i>
by: Qingru Chang, et al.
Published: (2023-11-01)

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci
by: Mary Joyce Wingler, et al.
Published: (2021-10-01)

Mechanisms of Linezolid Resistance in Mycobacteria
by: Wei Chong Gan, et al.
Published: (2023-05-01)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
by: Sarah S. Alghanem, et al.
Published: (2023-11-01)

Vancomycin versus linezolid for treatment of staphylococcal-associated central nervous system infections
by: Marin Lahouati, et al.
Published: (2025-03-01)

Linezolid Resistance Genes and Mutations among Linezolid-Susceptible <i>Enterococcus</i> spp.—A Loose Cannon?
by: Jennifer K. Bender, et al.
Published: (2024-01-01)

Comparative Study of Linezolid and Vancomycin Regimens in One-Stage Surgery for Treating Limb Traumatic Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus
by: Zhou Rongchang, et al.
Published: (2023-09-01)

Analysis of molecular epidemiological characteristics and antimicrobial susceptibility of vancomycin-resistant and linezolid-resistant Enterococcus in China
by: Ping Pan, et al.
Published: (2024-07-01)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
by: Estes Kerry S, et al.
Published: (2010-11-01)

A nomogram incorporating linezolid and metabolite concentrations for predicting linezolid induced thrombocytopenia in patients with renal impairment
by: Hanzhen Zhao, et al.
Published: (2024-10-01)

Molecular Characterization of Clinical Linezolid-Resistant <i>Staphylococcus epidermidis</i> in a Tertiary Care Hospital
by: Florian Campmann, et al.
Published: (2023-07-01)

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia—A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-08-01)

Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature Endocarditis por Enterococcus raffinosus resistente a vancomicina exitosamente tratada con linezolid: caso clínico y revisión de la literatura
by: A. Jasovich, et al.
Published: (2008-12-01)

Fosfomycin Enhances the Inhibition Ability of Linezolid Against Biofilms of Vancomycin-Resistant Enterococcus faecium in vitro
by: Chi J, et al.
Published: (2023-12-01)

The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis
by: Masoud Dadashi, et al.
Published: (2021-09-01)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01)

Management of linezolid-induced peripheral neuropathy
by: Rituja Tambe, et al.
Published: (2023-01-01)

Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data
by: Ming Ni, et al.
Published: (2022-04-01)

Usage of Tazocin/Vancomycin versus Tazocin/ Linezolid in the Treatment of Ventilator-Associated Pneumonia in Traumatized Contused Lungs
by: Mohamed Gaber Ibrahium Mostafa Allam
Published: (2020-08-01)

Enteral Linezolid as an Effective Option to Treat an Extremely Preterm Infant with <i>Bacillus cereus</i> Sepsis
by: Chiara Minotti, et al.
Published: (2022-03-01)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
by: Laia Fernández-Barat, et al.
Published: (2019-07-01)

Risk factors for linezolid-associated thrombocytopenia and negative effect of carbapenem combination
by: Esra Kaya Kılıç, et al.
Published: (2019-10-01)

Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
by: Kentaro Nagaoka, et al.
Published: (2022-06-01)

Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
by: Qi C, et al.
Published: (2019-11-01)

Whole-Genome Sequencing of Linezolid-Resistant and Linezolid-Intermediate-Susceptibility <i>Enterococcus faecalis</i> Clinical Isolates in a Mexican Tertiary Care University Hospital
by: Pedro Martínez-Ayala, et al.
Published: (2025-03-01)